Case 4: Metastatic Castration-Resistant Prostate Cancer With an HRR Alteration

Panelists discuss how the management of metastatic castration-resistant prostate cancer with a homologous recombination repair (HRR) alteration involves targeted therapies, such as PARP inhibitors, to exploit the genetic vulnerability and improve treatment response.

Video Player is loading.

Play Video

Play

Mute

Current Time 0:00

/

Duration 16:32

Loaded: 0.99%

00:00

Stream Type LIVE

Seek to live, currently behind liveLIVE

Remaining Time -16:32

 

1x

Playback Rate

Chapters

• Chapters

Descriptions

• descriptions off, selected

Captions

• captions settings, opens captions settings dialog
• captions off, selected

Audio Track

• en (Main), selected

Fullscreen

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

Text

ColorWhiteBlackRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-Transparent

Background

ColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentTransparent

Window

ColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyTransparentSemi-TransparentOpaque

Font Size

50%75%100%125%150%175%200%300%400%

Text Edge Style

NoneRaisedDepressedUniformDropshadow

Font Family

Proportional Sans-SerifMonospace Sans-SerifProportional SerifMonospace SerifCasualScriptSmall Caps

Reset restore all settings to the default valuesDone

Close Modal Dialog

End of dialog window.

Close Modal Dialog

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

EP: 1.Metastatic Castration-Sensitive Prostate Cancer (mCSPC) Overview

EP: 2.Case 1: Metastatic Castration- Sensitive Prostate Cancer (mCSPC)

EP: 3.Case 2: Low-Volume Recurrent mCSPC

EP: 4.Case 3: Nonmetastatic Castration-Sensitive Prostate Cancer With Biochemical Recurrence

Now Viewing

EP: 5.Case 4: Metastatic Castration-Resistant Prostate Cancer With an HRR Alteration

Related Videos

Case 3: Nonmetastatic Castration-Sensitive Prostate Cancer With Biochemical Recurrence

Case 2: Low-Volume Recurrent mCSPC

Case 1: Metastatic Castration- Sensitive Prostate Cancer (mCSPC)

Metastatic Castration-Sensitive Prostate Cancer (mCSPC) Overview